Acquisition of EGG-based influenza master and working seed lots derived from a/american wigeon/south carolina/22-000345-001/2021 (H5N1) candidate vaccine virus and fill-finish of any existing…
Ended Awarded Last action
- Contract number
- 75A50124F61016
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $1,650,051
Award facts
- Contract value 100% obligated
- $1,650,050.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,650,051 |
About this award
This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC to provide the acquisition of egg-based influenza master and working seed lots derived from a specific candidate vaccine virus, as well as fill-finish of any existing egg-based influenza vaccines. The order has a ceiling value of $1,650,050.61 and a completion date of February 21, 2026. No set-aside designation was used. Glaxosmithkline is the prime contractor and has previously held federal contracts and grants for a range of pharmaceutical products, including vaccines, treatments, and antivirals, with major customers across multiple civilian and defense agencies.
Description
Acquisition of EGG-based influenza master and working seed lots derived from a/american wigeon/south carolina/22-000345-001/2021 (H5N1) candidate vaccine virus and fill-finish of any existing EGG-based a/american wigeon/south carolina/22-000345/20
Quick answers
Who was awarded contract 75A50124F61016?
75A50124F61016 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 30, 2024.
How much is contract 75A50124F61016 worth?
The government has obligated $1,650,051 on 75A50124F61016.
Is contract 75A50124F61016 an order under another contract?
Yes. 75A50124F61016 is a delivery order under 75A50122D00002, an indefinite delivery contract.
Was contract 75A50124F61016 competed?
The extent of competition for 75A50124F61016 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award